Literature DB >> 18795256

Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation.

Stéphanie Ruiz, Emmanuelle Papy, Daniel Da Silva, Patrick Nataf, Laurent Massias, Michel Wolff, Lila Bouadma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18795256     DOI: 10.1007/s00134-008-1269-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment.

Authors:  Nilesh M Mehta; David R Halwick; Brenda L Dodson; John E Thompson; John H Arnold
Journal:  Intensive Care Med       Date:  2007-04-03       Impact factor: 17.440

Review 2.  Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates.

Authors:  Marcia L Buck
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.

Authors:  Andres Pascual; Thierry Calandra; Saskia Bolay; Thierry Buclin; Jacques Bille; Oscar Marchetti
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

4.  Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock.

Authors:  Alain Combes; Pascal Leprince; Charles-Edouard Luyt; Nicolas Bonnet; Jean-Louis Trouillet; Philippe Léger; Alain Pavie; Jean Chastre
Journal:  Crit Care Med       Date:  2008-05       Impact factor: 7.598

5.  In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus.

Authors:  Eric Dannaoui; Olivier Lortholary; Françoise Dromer
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

  5 in total
  18 in total

Review 1.  Drugs pharmacokinetics during veno-venous extracorporeal membrane oxygenation in pediatrics.

Authors:  Matteo Di Nardo; Enno Diederick Wildschut
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 2.  Optimising drug dosing in patients receiving extracorporeal membrane oxygenation.

Authors:  Vesa Cheng; Mohd-Hafiz Abdul-Aziz; Jason A Roberts; Kiran Shekar
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 3.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

4.  Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation.

Authors:  Kevin M Watt; Daniel K Benjamin; Ira M Cheifetz; Ganesh Moorthy; Kelly C Wade; P Brian Smith; Kim L R Brouwer; Edmund V Capparelli; Michael Cohen-Wolkowiez
Journal:  Pediatr Infect Dis J       Date:  2012-10       Impact factor: 2.129

Review 5.  [Clinical pharmacokinetics of anti-infective drugs in extracorporeal membrane oxygenation].

Authors:  A Reimer; H Vogl; S Schmid; S Gfrörer; M Bürle; M Hoffmann; G Geldner
Journal:  Anaesthesist       Date:  2019-12       Impact factor: 1.041

Review 6.  Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.

Authors:  Jennifer Sherwin; Travis Heath; Kevin Watt
Journal:  Clin Ther       Date:  2016-08-21       Impact factor: 3.393

7.  The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children.

Authors:  Enno D Wildschut; Annewil van Saet; Pavla Pokorna; Maurice J Ahsman; John N Van den Anker; Dick Tibboel
Journal:  Pediatr Clin North Am       Date:  2012-08-29       Impact factor: 3.278

8.  Insufficient serum caspofungin levels in a paediatric patient on ECMO.

Authors:  Birgit C P Koch; Enno D Wildschut; Anna L de Goede; Matthijs de Hoog; Roger J M Brüggemann
Journal:  Med Mycol Case Rep       Date:  2012-12-26

9.  Pharmacokinetics of caspofungin in critically ill patients on continuous renal replacement therapy.

Authors:  Stefan Weiler; Christoph Seger; Hartwig Pfisterer; Eva Stienecke; Florian Stippler; René Welte; Michael Joannidis; Andrea Griesmacher; Romuald Bellmann
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

Review 10.  Treatment and prophylaxis of invasive candidiasis.

Authors:  Nidhi Tripathi; Kevin Watt; Daniel K Benjamin
Journal:  Semin Perinatol       Date:  2012-12       Impact factor: 3.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.